![David Segarra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Segarra has founded two companies.
In 2010, he founded Aptus Biotech SL, where he held the title of Chief Executive Officer.
In 2014, he founded AptaTargets SL, where he currently holds the title of Chief Executive Officer & Director.
| Empresas | Cargo | Inicio |
|---|---|---|
AptaTargets SL
 AptaTargets SL Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses in developing therapeutic applications based on aptamer technology | Fundador | 01/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
Aptus Biotech SL
 Aptus Biotech SL BiotechnologyHealth Technology Research on new drugs and pronostic products using the technology of the aptamers, molecules capable of recognizing and activating therapeutic targets in a very efficient manner and with high specificity. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 2 |
|---|---|
Aptus Biotech SL
Aptus Biotech SL BiotechnologyHealth Technology Research on new drugs and pronostic products using the technology of the aptamers, molecules capable of recognizing and activating therapeutic targets in a very efficient manner and with high specificity. | Health Technology |
AptaTargets SL
AptaTargets SL Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses in developing therapeutic applications based on aptamer technology | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
